Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial

BACKGROUND: Unlike metastatic colorectal cancer (CRC) there are to date few reports concerning the predictive value of molecular biomarkers on the clinical outcome in stage II/III CRC patients receiving adjuvant chemotherapy. Aim of this study was to assess the predictive value of proteins related w...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomaidis, Thomas, Maderer, Annett, Formentini, Andrea, Bauer, Susanne, Trautmann, Mario, Schwarz, Michael, Neumann, Wiebke, Kittner, Jens Martin, Schad, Arno, Link, Karl-Heinrich, Rey, Johannes Wilhelm, Weinmann, Arndt, Hoffman, Arthur, Galle, Peter Robert, Kornmann, Marko, Moehler, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192339/
https://www.ncbi.nlm.nih.gov/pubmed/25272957
http://dx.doi.org/10.1186/s13046-014-0083-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192339/
https://www.ncbi.nlm.nih.gov/pubmed/25272957
http://dx.doi.org/10.1186/s13046-014-0083-8

Ejemplares similares